Condition
Male Erectile Disorder
ClinicalTrials.gov condition label
Clinical trials
6 shownFocal Therapy for Prostate Cancer Using HIFUNCT01194648 · 2011-06-29
RECRUITINGPentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate CancerNCT03830164 · 2019-11-20
COMPLETEDVacuum Erection Device in Improving Recovery of Erectile Function in Patients With Prostate Cancer Undergoing SurgeryNCT01660152 · 2011-09-01
COMPLETEDL-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer SurvivorsNCT01105130 · 2010-10-01
COMPLETEDHelping African American Prostate Cancer Survivors and Their Partners Cope With Challenges After Surgery for Prostate CancerNCT00869739 · 2008-08-01
COMPLETEDED Recovery in Men Age </=65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy for Prostate CancerNCT00544076 · 2006-01-01
TERMINATEDCommon interventions
quality-of-life assessmentPROCEDURE3questionnaire administrationOTHER3alprostadilDRUG1assessment of therapy complicationsPROCEDURE1AtorvastatinDRUG1Daily vacuum therapyPROCEDURE1educational interventionOTHER1high-intensity focused ultrasound ablationPROCEDURE1management of therapy complicationsPROCEDURE1multiparametric magnetic resonance imagingPROCEDURE1Oral L-ArginineDRUG1partner-assisted coping skills trainingOTHER1PentoxifyllineDRUG1PlaceboOTHER1psychosocial assessment and carePROCEDURE1robotic-assisted laparoscopic surgeryPROCEDURE1Sexual Health Inventory for Men (SHIM) questionnaire administrationOTHER1sildenafil citrateDRUG1telephone-based interventionBEHAVIORAL1transperineal prostate biopsyPROCEDURE1transrectal prostate biopsyPROCEDURE1Vitamin E CompoundDIETARY_SUPPLEMENT1
Leading sponsors
Trial status mix
COMPLETED4
RECRUITING1
TERMINATED1
Phase mix
NA3
PHASE22
PHASE31
How to interpret this record
CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.